Michael J. McCall
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Radiopharmaceutical Chemistry and Applications 19
- Monoclonal and Polyclonal Antibodies Research 17
- Medical Imaging Techniques and Applications 2
-
- Protein purification and stability 4
- Co-authors
- Claude F. Meares (21 shared papers)David A. Goodwin (10 shared papers)Sally J. DeNardo (10 shared papers)Maureen McTigue (7 shared papers)Min K. Moi (6 shared papers)Carol I. Diamanti (5 shared papers)Gerald L. DeNardo (7 shared papers)William C. Cole (3 shared papers)
- Journals
- Analytical Biochemistry (2 papers)Bioconjugate Chemistry (1 paper)Molecular Physics (1 paper)Analytical Chemistry (1 paper)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Michael J. McCall
29 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 90
- Radiology, Nuclear Medicine and Imaging 1.2k
- Oncology 427
- Pulmonary and Respiratory Medicine 216
- Pathology and Forensic Medicine 114
- Organic Chemistry 179
Countries citing papers authored by Michael J. McCall
This map shows the geographic impact of Michael J. McCall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. McCall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. McCall more than expected).
Fields of papers citing papers by Michael J. McCall
This network shows the impact of papers produced by Michael J. McCall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. McCall. The network helps show where Michael J. McCall may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael J. McCall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1984 | 332 | |
| 2 | 1985 | 162 | |
| 3 | Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. | 1988 | 160 |
| 4 | Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent. | 1990 | 127 |
| 5 | Comparative serum stability of radiochelates for antibody radiopharmaceuticals. | 1987 | 88 |
| 6 | Copper-67-labeled monoclonal antibody Lym-1, a potential radiopharmaceutical for cancer therapy: labeling and biodistribution in RAJI tumored mice. | 1988 | 88 |
| 7 | 1990 | 82 | |
| 8 | Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy. | 1992 | 74 |
| 9 | Macrocyclic chelates of radiometals for diagnosis and therapy. | 1990 | 48 |
| 10 | 1986 | 47 | |
| 11 | 1986 | 47 | |
| 12 | Metabolism of indium chelates attached to monoclonal antibody: minimal transchelation of indium from benzyl-EDTA chelate in vivo. | 1990 | 45 |
| 13 | Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake. | 1992 | 41 |
| 14 | 1986 | 34 | |
| 15 | Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse. | 1985 | 30 |
| 16 | Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice. | 1989 | 26 |
| 17 | 1988 | 23 | |
| 18 | 1989 | 16 | |
| 19 | 2002 | 14 | |
| 20 | 2008 | 13 |
About Michael J. McCall
Michael J. McCall is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Oncology, Materials Chemistry and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 1.5k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (19 papers), Monoclonal and Polyclonal Antibodies Research (17 papers), HER2/EGFR in Cancer Research (4 papers), Protein purification and stability (4 papers), Medical Imaging and Pathology Studies (3 papers), Nursing education and management (2 papers), Medical Imaging Techniques and Applications (2 papers) and Catalytic Processes in Materials Science (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.2k citations), Oncology (427 citations), Pulmonary and Respiratory Medicine (216 citations), Pathology and Forensic Medicine (114 citations) and Organic Chemistry (179 citations). Michael J. McCall has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Claude F. Meares, David A. Goodwin, Sally J. DeNardo, Maureen McTigue, Min K. Moi, Carol I. Diamanti, Gerald L. DeNardo, William C. Cole, Warak Chaovapong and S.V. Deshpande. Their work appears in journals such as Analytical Biochemistry, Bioconjugate Chemistry, Molecular Physics, Analytical Chemistry and European Journal of Nuclear Medicine and Molecular Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.